70% of patients consider online reviews important when selecting a healthcare provider and 75% of people have searched for a physician online according to a recent survey from Patientpop. With reviews playing such a pivotal role in discovery, gathering reviews is not only essential as a marketing tool but also as a mechanism for clinicians to address issues that may be resulting in less than stellar patient satisfaction. Doctify is the tech-enabled healthcare review platform that provides both patients and healthcare providers with valuable insights. Founded by two physicians in 2015, the platform also offers patients the ability to schedule appointments and teleconsultations. Doctify is offered on a subscription basis to the healthcare provider and is free to use for patients. London TechWatch caught up with CEO and Cofounder Stephanie Eltz to learn more about the business, the company’s strategic expansion plans to further support its mission to keep both patients and healthcare providers informed, latest funding round from investors that include Keen Venture Partners, Amadeus Capital, Guinness Asset Management, and Tom Teichman.
Healthcare
Bea Fertility Raises $1M for its At-Home Subscription Fertility Treatment Service
The global fertility market is estimated to grow to ~$50B by 2030 with nearly 1/8 couples having trouble conceiving. Advances in technology are making reproductive health options more accessible from both a convenience and affordability standpoint. Bea Fertility is a healthcare startup offering at-home fertility treatments via a kit offered through subscription. Traditional fertility options like IVF need to be done at a fertility center and come at exorbitant cost. Bea uses ICI, a technique that’s similarly effective to other treatment options, but only costs £300/month. The company is focused on supporting the entire conception journey and offers ovulation tracking, guidance, and an expert network. Presently pre-launch, Bea is in the process of gaining regulatory approval and expects to launch by the end of the year. London TechWatch caught up with CEO and Cofounder Tess Cosad to learn more about the importance of making fertility treatments accessible, the company’s upcoming launch, strategic plans, and recent round of funding from Calm/Storm VC and QVentures.
Prokarum Raises $21M to Develop Microbial Cancer Immunotherapies and Vaccines
Prokarium is developing Vesibax, an innovative, safe, and effective microbial immunotherapy (MI) for early-stage bladder cancer, a disease with afflicts over 550,000 individuals globally every year. CEO Ted Fjallman to learn more about Prokarium’s upcoming pipeline of novel therapies, its current focus, and recent funding round from investors that include Korea Investment Partners (KIP), Flerie Invest, Riyadh Valley Company (RVC), and the UK Government’s Future Fund.
Log my Care Raises £600K to Enable Care Homes to Improve Care With Software
Approximately 70%-80% of care homes are reliant on pen and paper and manual processes to run their operations and record data. Log my Care is the free care management software platform that features an intuitive interface that enables care providers to deliver exceptional care and record plans with a few clicks. Founder Sam Hussain shares some more insight on the inspiration for the company, how the pandemic led to the rapid development of new features, and the company’s latest funding round.
Farewill Raises £20M to Make it Easy to Deal With Death
Dealing with death is never easy and it often adds stress at a time when a family needs it the least. Farewill provides efficient, affordable, and simple will writing service online as well as probate and direct cremation options. Cofounder and CEO Dan Garrett walks us through how the company transforms an industry that has been doing things the same ways for 150+ years, the company’s future plans, response to COVID deaths, and recent funding round led by Highland Europe.
Lifebit Raises $7.5M to Process Big Data for Medical Research, Redefining Bioinformatics
It’s an unprecedented time to study genetics because technological advancements and the raw computational power available are helping scientists make sense of DNA in an unprecedented way. Lifebit CEO Dr. Maria Chatzou Dunford offers some insight on how her company’s platform allows researchers to analyse data faster than ever and extract actionable insights to develop better drugs, therapies, diagnostics, and products.
Vine Health Raises £1.2M to Create The Behavioral App that Empowers Cancer Patients with Information
Vine Health is the digital app that allows cancer patients to track, understand, and optimize their care. During treatment, patients can use this app to log their symptoms and reactions to various medications, which gives Vine Health the ability to capture large-scale data on how different drugs affect patients’ quality of life. London TechWatch spoke […]
Zava Raises $32M to Make Going to the Doctor’s Office a Thing of the Past
According to studies, the average human lies at least two to three times during a 10-minute, everyday conversation. That number jumps when examining conversation with doctors. Zava, a leader in digital healthcare through its discreet service, allows you to be honest with your doctor without fear of judgement. The London startup sends patients online questionnaires abiout their […]
Lumeon Raises Another $28M for its End-to-End Platform That Brings Consistency to Healthcare
How can healthcare providers deliver consistently high-quality care, everywhere? Lumeon is the London-based healthcare company responding directly to this question through its Care Pathway Management (CPM) platform. Designed to lower operational costs and engage patients, the CPM platform provides a 360 degree perspective of a patient’s care plan to optimize all the moving parts in […]
Raremark Raises £3M Because Suffering From a Rare Health Condition Should Not Mean Struggling to Find Information
After helplessly watching several members of her family being treated for rare health conditions, where there isn’t often a wide body of knowledge, Julie Walters came to the realization that there was a definite need for a database with both scholarly information and first-hand knowledge from people with rare diseases. Her experience drew her to launch Raremark. […]